Kavanaugh, A., Mease, P. J., Gómez-Reino, J. J., Adebajo, A. O., Wollenhaupt, J., Gladman, D. D., . . . Schett, G. (2014). Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Kavanaugh, Arthur, et al. Treatment of Psoriatic Arthritis in a Phase 3 Randomised, Placebo-controlled Trial with Apremilast, an Oral Phosphodiesterase 4 Inhibitor. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014.
MLA-Zitierstil (9. Ausg.)Kavanaugh, Arthur, et al. Treatment of Psoriatic Arthritis in a Phase 3 Randomised, Placebo-controlled Trial with Apremilast, an Oral Phosphodiesterase 4 Inhibitor. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014.